Nasus Pharma Ltd Increase Decrease In Operating Lease Liability
Nasus Pharma Ltd (NSRX) reported Increase Decrease In Operating Lease Liability of -$27.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-03-25
| Period end | Increase Decrease In Operating Lease Liability 12 month |
|---|---|
| 2025-12-31 | -$27.00K 20-F · filed 2026-03-25 |